Publication: Dynamics of B-Cell Responses after SARS-CoV-2 Vaccination in Spain.
dc.contributor.author | Jose-Cascon, Miriam San | |
dc.contributor.author | de la Varga-Martinez, Raquel | |
dc.contributor.author | Campos-Caro, Antonio | |
dc.contributor.author | Rodriguez, Carmen | |
dc.contributor.funder | Instituto de Salud Carlos III | |
dc.contributor.funder | European Regional Development Fund/European Social Fund, “Investing in your future” | |
dc.date.accessioned | 2023-05-03T14:24:28Z | |
dc.date.available | 2023-05-03T14:24:28Z | |
dc.date.issued | 2022-09-19 | |
dc.description.abstract | The high mortality rate due to COVID-19 has necessitated the mass vaccination against SARS-CoV-2 to induce protective humoral and cellular immunity. (1) Objective: To study the dynamics of SARS-CoV-2-specific B cells after two doses of the Pfizer-BioNTech SARS-CoV-2 vaccine. (2) Methods: Immunophenotyping and cellular cultures were used to determine the kinetics of B-cell subpopulations and vaccine responses in volunteers before and seven days, three months and seven months after the second dose in Spain (n = 19). (3) Results: Seven days after immunisation, memory B cells and plasmablasts expressing receptors for factors implicated in the maturation of plasma cells were augmented in blood. Three months after vaccination, SARS-CoV-2 spike-specific plasmablasts disappeared from circulation while spike-specific memory-B cells circulated, with heterogeneous dynamics among individuals. (4) Conclusion: After vaccination, specific plasmablasts equipped with receptors for maturation factors were quickly generated and disappeared rapidly from the blood, while specific memory B cells circulated for at least seven months. | |
dc.description.version | Si | |
dc.identifier.citation | José-Cascón MS, de la Varga-Martínez R, Campos-Caro A, Rodríguez C. Dynamics of B-Cell Responses after SARS-CoV-2 Vaccination in Spain. Vaccines (Basel). 2022 Sep 26;10(10):1615 | |
dc.identifier.doi | 10.3390/vaccines10101615 | |
dc.identifier.issn | 2076-393X | |
dc.identifier.pmc | PMC9608951 | |
dc.identifier.pmid | 36298479 | |
dc.identifier.pubmedURL | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9608951/pdf | |
dc.identifier.unpaywallURL | https://www.mdpi.com/2076-393X/10/10/1615/pdf?version=1665713899 | |
dc.identifier.uri | http://hdl.handle.net/10668/21611 | |
dc.issue.number | 10 | |
dc.journal.title | Vaccines | |
dc.journal.titleabbreviation | Vaccines (Basel) | |
dc.language.iso | en | |
dc.organization | Hospital Universitario Puerta del Mar | |
dc.organization | Instituto de Investigación e Innovación en Ciencias Biomédicas | |
dc.page.number | 10 | |
dc.publisher | MDPI | |
dc.pubmedtype | Journal Article | |
dc.relation.projectID | PI15/01147 | |
dc.relation.publisherversion | https://www.mdpi.com/2076-393X/10/10/1615 | |
dc.rights | Attribution 4.0 International | |
dc.rights.accessRights | open access | |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
dc.subject | B cell | |
dc.subject | COVID-19 | |
dc.subject | SARS-CoV-2 | |
dc.subject | Plasma cell | |
dc.subject | Plasmablast | |
dc.subject | Vaccine immunogenicity | |
dc.subject.decs | Células B de memoria | |
dc.subject.decs | Células plasmáticas | |
dc.subject.decs | España | |
dc.subject.decs | Inmunidad celular | |
dc.subject.decs | Inmunofenotipificación | |
dc.subject.decs | Vacunación masiva | |
dc.subject.decs | Vacunas contra la COVID-19 | |
dc.subject.mesh | COVID-19 vaccines | |
dc.subject.mesh | SARS-CoV-2 | |
dc.subject.mesh | Immunophenotyping | |
dc.subject.mesh | Mass vaccination | |
dc.subject.mesh | Memory B cells | |
dc.subject.mesh | Plasma cells | |
dc.subject.mesh | Spain | |
dc.subject.mesh | COVID-19 | |
dc.subject.mesh | Immunity, cellular | |
dc.title | Dynamics of B-Cell Responses after SARS-CoV-2 Vaccination in Spain. | |
dc.type | Research article | |
dc.type.hasVersion | VoR | |
dc.volume.number | 10 | |
dspace.entity.type | Publication |